Pimobendan丨CAS 74150-27-9

Pimobendan丨74150-27-9 is a cardiovascular drug primarily used to treat heart failure in both humans and animals, especially in veterinary medicine for the management of canine dilated cardiomyopathy (DCM) and congestive heart failure (CHF). It belongs to the class of drugs known as inodilators, which combine the effects of positive inotropy (increasing the force of heart contraction) and vasodilation (widening blood vessels). Pimobendan is especially valuable in the management of heart conditions because it improves the heart's pumping ability while simultaneously reducing the workload on the heart by dilating blood vessels.

Pimobendan is used to treat various heart conditions due to its inotropic and vasodilatory effects, including:

Canine Dilated Cardiomyopathy (DCM):

Pimobendan is commonly prescribed for dogs diagnosed with DCM, a condition in which the heart becomes enlarged and weakened, leading to reduced ability to pump blood. Pimobendan helps improve heart function, increase exercise tolerance, and reduce clinical signs of heart failure.

Canine Congestive Heart Failure (CHF):

In dogs with congestive heart failure due to either DCM or mitral valve disease, pimobendan improves the pumping function of the heart, reduces the symptoms of heart failure (such as fluid retention), and improves overall quality of life. It can be used alone or in combination with other heart failure medications (such as ACE inhibitors or diuretics).

Human Use (Limited):

Pimobendan丨74150-27-9 has been explored for human use, particularly for the management of chronic heart failure. However, it is not commonly used in human medicine, as other agents, like ACE inhibitors and beta-blockers, have more established roles. Some studies have shown potential benefits in patients with heart failure with preserved ejection fraction (HFpEF), but further research is needed to determine its broader application in humans.

Veterinary Use:

Pimobendan is one of the most frequently prescribed drugs for heart failure in dogs, particularly because of its effectiveness and relatively low side effect profile. It is available in tablet form, often under brand names like Vetmedin.

Improved Cardiac Function:

Pimobendan丨74150-27-9 enhances contractility and reduces the workload on the heart. This improves the ejection fraction (the percentage of blood pumped out of the heart with each beat), which is often reduced in heart failure.

Dual Action (Inotropic + Vasodilation):

Unlike many other inotropic agents, pimobendan not only increases the force of heart contractions but also dilates blood vessels, making it particularly effective for managing congestive heart failure.

Improved Quality of Life:

By relieving symptoms such as exercise intolerance, fatigue, and fluid accumulation, pimobendan helps improve the quality of life for pets with heart failure, especially in conditions like DCM and mitral valve disease.

Safe for Long-Term Use:

Pimobendan has a good safety profile when used appropriately and can be administered long-term to manage chronic heart conditions. It's one of the preferred drugs for treating canine heart failure because it does not worsen the condition as certain other inotropic drugs (like digoxin) may.

Minimal Impact on Heart Rate:

Unlike some other inotropic agents, pimobendan does not significantly increase heart rate, which helps minimize the risk of tachycardia (abnormally high heart rate).

Pimobendan丨74150-27-9 is a highly effective and widely used drug for managing heart failure in animals, especially dogs with canine dilated cardiomyopathy and congestive heart failure. Its dual action as a positive inotrope and vasodilator makes it an ideal treatment for improving cardiac output and reducing the symptoms of heart failure, thereby enhancing the quality of life for affected animals. While it is generally well tolerated, like any medication, it requires proper dosing and monitoring to minimize the risk of side effects and drug interactions. Though its use in humans is not widespread, its success in veterinary medicine has made it an indispensable tool for treating certain types of heart failure.